BENTONVILLE, Ariz., Feb. 27, 2018 -- via OTC PR WIRE-- Glucose Health, Inc. (OTC:GLUC) today announced the completion of its second TV commercial to support national expansion of its newest diabetic nutritional product, Glucose Health® Diabetic-Friendly Iced Tea. The key message to consumers of the 30 second commercial is “The Iced Tea That’s Good for You!”
The new TV commercial will be part of a national multi-channel media strategy to support Glucose Health® Diabetic-Friendly Iced Tea national sales expansion though “brick & mortar” retailer partners.
Watch the new TV commercial at the Glucose Health, Inc. corporate website at this link.
Glucose Health® Diabetic-Friendly Iced Tea Mix is more than just a delicious, sugar-free and decaffeinated iced tea – it’s also a potent nutritional supplement. Glucose Health® is enriched with key micronutrients relevant to persons concerned about diabetes, including Vitamins B6, B7, B12 and high bioavailability forms of the trace elements Manganese, Chromium and Zinc. Additionally, every serving of Glucose Health® Diabetic-Friendly Iced Tea includes 100% soluble fiber, clinically proven in research published in peer-reviewed medical journals to help “block” the body’s absorption of dietary sugars (and dietary fats) and to help moderate rising blood sugar levels, after meals.
About Glucose Health, Inc. (OTC:GLUC)
Glucose Health® Diabetic-Friendly Iced Tea Mix is a unique and compelling functional beverage which serves the fast-growing over-the-counter (non-prescription) diabetic nutritionals category. Glucose Health, Inc. is publicly-traded with the ticker symbol (OTC:GLUC). Glucose Health® products are manufactured in the USA in Arkansas and Minnesota.
Contact:
Glucose Health, Inc.
Murray Fleming
(888) 987-6315


Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
DeepSeek to Raise AI API Prices as Demand for New Models Surges 



